Article Text

PDF

Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma.
  1. J C Hill,
  2. R Sealy,
  3. D Shackleton,
  4. C Stannard,
  5. J Korrubel,
  6. E Hering and
  7. C Loxton
  1. Department of Ophthalmology, Groote Schuur Hospital.

    Abstract

    The use and development of iodine-125 plaque therapy for choroidal malignant melanoma are described. Since 1975 experience has led to changes in plaque design and insertion techniques. Twenty-one patients were irradiated with local episcleral iodine-125 plaques. Three patients required a second plaque for tumour recurrence. Four eyes were enucleated because of continued tumour growth and a further eye was removed because of glaucoma secondary to radiation retinopathy. Two patients (9.5%) died of metastases. The remaining 19 patients are alive and clinically clear of metastases, with a mean follow up time of 73.1 months (range 43-142 months).

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.